FONG JAMES K (See Remarks) sold 96.6% of their position (100K shares) of CTI BIOPHARMA CORP on the open market
Open‑market sale worth $600.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/26/2023ACC: 0000891293-23-000003
Officer· See Remarks
Since Feb 2022
+188K
Net shares
Net buyer
$600.0K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
388K acquired · 200K disposed
Non-Derivative Transactions2
common stock
Direct
Shares
+100K
Price / share
$0.95
Trade value
$94.89K
% of position
2805.0%
1/24/2023
3.56K→103.56K
common stock
Direct
Shares
−100K
Price / share
$6.00
Trade value
$600K
% of position
96.6%
1/24/2023
103.56K→3.56K
Total
Net shares
+0.00
Net value
-$505.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| common stock Direct | 1/24/2023 | M · Option Exercise | +100K | $0.95 | $94.89K | 2805.0% | 3.56K | 103.56K |
| common stock Direct | 1/24/2023 | S · Sale | −100K | $6.00 | $600K | 96.6% | 103.56K | 3.56K |
| Total | +0.00 | -$505.11K | ||||||
Derivative Transactions2
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
288K shares
Shares
+288K
Strike price
0.9489
Held after
288K
Exercisable
—
2/19/2019
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
100K shares
Shares
−100K
Strike price
0.9489
Held after
188K
Exercisable
—
1/24/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock288K shares | 2/19/2019 | A · Award | +288K | 0.9489 | — | 288K |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock100K shares | 1/24/2023 | M · Option Exercise | −100K | 0.9489 | — | 188K |